142 related articles for article (PubMed ID: 16217764)
21. Multiplexed bead-based immunoassay of four serum biomarkers for diagnosis of ovarian cancer.
Kim YW; Bae SM; Kim IW; Liu HB; Bang HJ; Chaturvedi PK; Battogtokh G; Lim H; Ahn WS
Oncol Rep; 2012 Aug; 28(2):585-91. PubMed ID: 22641176
[TBL] [Abstract][Full Text] [Related]
22. Relationship of tumor marker CA125 and ovarian tumor stem cells: preliminary identification.
Zhang H; Yang Y; Wang Y; Gao X; Wang W; Liu H; He H; Liang Y; Pan K; Wu H; Shi J; Xue H; Liang L; Cai Z; Fan Y; Zhang Y
J Ovarian Res; 2015 Mar; 8():19. PubMed ID: 25886959
[TBL] [Abstract][Full Text] [Related]
23. Statistical interpretation of CA125 and Bcl-2 in serum of patients with late stage ovarian cancer.
Camlica H; Duranyildiz D; Tas F; Yasasever V
Am J Clin Oncol; 2008 Dec; 31(6):585-8. PubMed ID: 19060592
[TBL] [Abstract][Full Text] [Related]
24. CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study.
Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Kjaerbye-Thygesen A; Gayther S; Jacobs IJ; Høgdall CK
Gynecol Oncol; 2007 Mar; 104(3):508-15. PubMed ID: 17113137
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward?
Azzam AZ; Hashad DI; Kamel NA
Arch Gynecol Obstet; 2013 Jul; 288(1):167-72. PubMed ID: 23361457
[TBL] [Abstract][Full Text] [Related]
26. [Expression of hSef and FGF-2 in epithelial ovarian tumor].
Feng QL; Shi HR; Qiao LJ; Zhao J
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):770-4. PubMed ID: 22335910
[TBL] [Abstract][Full Text] [Related]
27. Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic?
Sparholt MH; Høgdall CK; Nedergaard L; Heeran MC; Christensen IJ; Høgdall EV
APMIS; 2013 Jan; 121(1):38-44. PubMed ID: 23030299
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer.
Simon I; Liu Y; Krall KL; Urban N; Wolfert RL; Kim NW; McIntosh MW
Gynecol Oncol; 2007 Jul; 106(1):112-8. PubMed ID: 17490732
[TBL] [Abstract][Full Text] [Related]
29. Personalizing CA125 levels for ovarian cancer screening.
Dorigo O; Berek JS
Cancer Prev Res (Phila); 2011 Sep; 4(9):1356-9. PubMed ID: 21893498
[TBL] [Abstract][Full Text] [Related]
30. Preoperative plasma osteopontin level as a biomarker complementary to carbohydrate antigen 125 in predicting ovarian cancer.
Nakae M; Iwamoto I; Fujino T; Maehata Y; Togami S; Yoshinaga M; Douchi T
J Obstet Gynaecol Res; 2006 Jun; 32(3):309-14. PubMed ID: 16764622
[TBL] [Abstract][Full Text] [Related]
31. A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA.
Zhang Q; Hu G; Yang Q; Dong R; Xie X; Ma D; Shen K; Kong B
Gynecol Oncol; 2013 Jul; 130(1):132-9. PubMed ID: 23623832
[TBL] [Abstract][Full Text] [Related]
32. The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.
Luo LY; Katsaros D; Scorilas A; Fracchioli S; Bellino R; van Gramberen M; de Bruijn H; Henrik A; Stenman UH; Massobrio M; van der Zee AG; Vergote I; Diamandis EP
Cancer Res; 2003 Feb; 63(4):807-11. PubMed ID: 12591730
[TBL] [Abstract][Full Text] [Related]
33. Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression.
Rangel LB; Sherman-Baust CA; Wernyj RP; Schwartz DR; Cho KR; Morin PJ
Oncogene; 2003 Oct; 22(46):7225-32. PubMed ID: 14562052
[TBL] [Abstract][Full Text] [Related]
34. Characterization of serum biomarkers for detection of early stage ovarian cancer.
Kozak KR; Su F; Whitelegge JP; Faull K; Reddy S; Farias-Eisner R
Proteomics; 2005 Nov; 5(17):4589-96. PubMed ID: 16237736
[TBL] [Abstract][Full Text] [Related]
35. Combination of serum biomarkers to differentiate malignant from benign ovarian tumours.
He G; Holcroft CA; Beauchamp MC; Yasmeen A; Ferenczy A; Kendall-Dupont J; Mes-Masson AM; Provencher D; Gotlieb WH
J Obstet Gynaecol Can; 2012 Jun; 34(6):567-574. PubMed ID: 22673173
[TBL] [Abstract][Full Text] [Related]
36. Combination of IL-6, IL-10, and MCP-1 with traditional serum tumor markers in lung cancer diagnosis and prognosis.
Pan YW; Zhou ZG; Wang M; Dong JQ; Du KP; Li S; Liu YL; Lv PJ; Gao JB
Genet Mol Res; 2016 Nov; 15(4):. PubMed ID: 27819723
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous Measurement of 92 Serum Protein Biomarkers for the Development of a Multiprotein Classifier for Ovarian Cancer Detection.
Skubitz APN; Boylan KLM; Geschwind K; Cao Q; Starr TK; Geller MA; Celestino J; Bast RC; Lu KH; Koopmeiners JS
Cancer Prev Res (Phila); 2019 Mar; 12(3):171-184. PubMed ID: 30709840
[TBL] [Abstract][Full Text] [Related]
38. Anti-CA15.3 and Anti-CA125 Antibodies and Ovarian Cancer Risk: Results from the EPIC Cohort.
Cramer DW; Fichorova RN; Terry KL; Yamamoto H; Vitonis AF; Ardanaz E; Aune D; Boeing H; Brändstedt J; Boutron-Ruault MC; Chirlaque MD; Dorronsoro M; Dossus L; Duell EJ; Gram IT; Gunter M; Hansen L; Idahl A; Johnson T; Khaw KT; Krogh V; Kvaskoff M; Mattiello A; Matullo G; Merritt MA; Nodin B; Orfanos P; Onland-Moret NC; Palli D; Peppa E; Quirós JR; Sánchez-Perez MJ; Severi G; Tjønneland A; Travis RC; Trichopoulou A; Tumino R; Weiderpass E; Fortner RT; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2018 Jul; 27(7):790-804. PubMed ID: 29661801
[No Abstract] [Full Text] [Related]
39. [Comparison of VEGF, IL-8 and beta-FGF concentrations in the serum and ascites of patients with ovarian cancer].
Sadłecki P; Walentowicz-Sadłecka M; Szymański W; Grabiec M
Ginekol Pol; 2011 Jul; 82(7):498-502. PubMed ID: 21913426
[TBL] [Abstract][Full Text] [Related]
40. SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and/or each other.
Hellstrom I; Hellstrom KE
Adv Exp Med Biol; 2008; 622():15-21. PubMed ID: 18546615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]